Search research articles
Contact Us
Filters
Showing results (71-80 of 349) with videos related to
Page
of 35
Sort By:
Clinical Pharmacology and Therapeutics
|
December 1, 1994
Pharmacological actions of l-deprenyl (selegiline) and other selective monoamine oxidase B inhibitors
M B Youdim, J P Finberg
Neuropharmacology
|
March 1, 1983
Selective MAO A and B inhibitors: their mechanism of action and pharmacology
J P Finberg, M B Youdim
Advances in Biochemical Psychopharmacology
|
January 1, 1972
The flavin prosthetic group of purified rat liver mitochondrial monoamine oxidase
M B Youdim, T L Sourkes
Biochemical Pharmacology
|
February 1, 1975
The influence of tissue environment on the rates of metabolic processes and the properties of enzymes
M B Youdim, H F Woods
Modern Problems of Pharmacopsychiatry
|
January 1, 1983
Implications of MAO-A and MAO-B inhibition for antidepressant therapy
M B Youdim, J P Finberg
European Journal of Pharmacology
|
March 16, 1995
Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine
Y Y Glinka, M B Youdim
Biochemical Pharmacology
|
January 15, 1991
New directions in monoamine oxidase A and B selective inhibitors and substrates
M B Youdim, J P Finberg
Advances in Neurology
|
January 1, 1987
MAO type B inhibitors as adjunct to L-dopa therapy
M B Youdim, J P Finberg
Biochemical Pharmacology
|
March 15, 1975
The binding of (14C)phenethylhydrazine to rat liver monoamine oxidase
G G Collins, M B Youdim
The Biochemical Journal
|
April 1, 1970
Multiple forms of human brain monoamine oxidase: substrate specificities
G G Collins, M B Youdim
Page
of 35
Search research articles
Search
Showing results (71-80 of 349) with videos related to
Sort By:
Page
of 35
Clinical Pharmacology and Therapeutics
|
December 1, 1994
Pharmacological actions of l-deprenyl (selegiline) and other selective monoamine oxidase B inhibitors
M B Youdim, J P Finberg
Neuropharmacology
|
March 1, 1983
Selective MAO A and B inhibitors: their mechanism of action and pharmacology
J P Finberg, M B Youdim
Advances in Biochemical Psychopharmacology
|
January 1, 1972
The flavin prosthetic group of purified rat liver mitochondrial monoamine oxidase
M B Youdim, T L Sourkes
Biochemical Pharmacology
|
February 1, 1975
The influence of tissue environment on the rates of metabolic processes and the properties of enzymes
M B Youdim, H F Woods
Modern Problems of Pharmacopsychiatry
|
January 1, 1983
Implications of MAO-A and MAO-B inhibition for antidepressant therapy
M B Youdim, J P Finberg
European Journal of Pharmacology
|
March 16, 1995
Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine
Y Y Glinka, M B Youdim
Biochemical Pharmacology
|
January 15, 1991
New directions in monoamine oxidase A and B selective inhibitors and substrates
M B Youdim, J P Finberg
Advances in Neurology
|
January 1, 1987
MAO type B inhibitors as adjunct to L-dopa therapy
M B Youdim, J P Finberg
Biochemical Pharmacology
|
March 15, 1975
The binding of (14C)phenethylhydrazine to rat liver monoamine oxidase
G G Collins, M B Youdim
The Biochemical Journal
|
April 1, 1970
Multiple forms of human brain monoamine oxidase: substrate specificities
G G Collins, M B Youdim
Page
of 35